Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, 1703 East Mabel Street, Tucson, AZ 85721, USA.
Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, 1703 East Mabel Street, Tucson, AZ 85721, USA; University of Arizona Cancer Center, University of Arizona, Tucson, AZ 85724, USA.
Cell Chem Biol. 2020 Apr 16;27(4):436-447. doi: 10.1016/j.chembiol.2020.03.011. Epub 2020 Apr 9.
Ferroptosis is a non-apoptotic mode of regulated cell death that is iron and lipid peroxidation dependent. As new mechanistic insight into ferroptotic effectors and how they are regulated in different disease contexts is uncovered, our understanding of the physiological and pathological relevance of this mode of cell death continues to grow. Along these lines, a host of pharmacological modulators of this pathway have been identified, targeting proteins involved in iron homeostasis; the generation and reduction of lipid peroxides; or cystine import and glutathione metabolism. Also, of note, many components of the ferroptosis cascade are target genes of the transcription factor nuclear factor erythroid 2-related factor 2 (NRF2), indicating its critical role in mediating the ferroptotic response. In this review, we discuss the in vitro, in vivo, and clinical evidence of ferroptosis in disease, including a brief discussion of targeting upstream mediators of this cascade, including NRF2, to treat ferroptosis-driven diseases.
铁死亡是一种铁依赖性和脂质过氧化依赖性的非凋亡细胞死亡模式。随着对铁死亡效应物及其在不同疾病背景下如何被调控的新机制见解的揭示,我们对这种细胞死亡方式的生理和病理相关性的理解不断加深。沿着这些思路,已经鉴定出许多该途径的药理学调节剂,靶向参与铁稳态的蛋白质;脂质过氧化物的产生和还原;或胱氨酸导入和谷胱甘肽代谢。同样值得注意的是,铁死亡级联反应的许多成分都是转录因子红细胞生成 2 相关因子 2(NRF2)的靶基因,表明其在介导铁死亡反应中起着关键作用。在这篇综述中,我们讨论了铁死亡在疾病中的体外、体内和临床证据,包括简要讨论了靶向该级联反应的上游调节剂,包括 NRF2,以治疗铁死亡驱动的疾病。